January 16, 2025- Henry Schein, Inc. announced it has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Henry Schein announced the agreement to acquire Acentus on November 20, 2024.
Headquartered in Tampa, Florida, Acentus reports annual revenue of approximately $35 million. Henry Schein expects the transaction to be neutral to 2025 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.
The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic commitment to the homecare medical supplies market. Henry Schein’s homecare medical products platform will now have an annual revenue base in excess of $350 million.
Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein and bring their expertise and experience in the product category and the health care industry.